Jeanne de la Roche

Jeanne de la Roche

Auto-generated profile, based on publicly available information

Jeanne de la Roche

Institute for Neurophysiology, Hannover Medical School, Hannover, Germany

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2021 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
LDLika Drakhlis
Lika Drakhlis
SBSantoshi Biswanath
Santoshi Biswanath
CFClara-Milena Farr
Clara-Milena Farr
VLVictoria Lupanow
Victoria Lupanow
JTJana Teske
Jana Teske
Robert ZweigerdtRobert Zweigerdt
Robert Zweigerdt
Organoid models of early tissue development have been produced for the intestine, brain, kidney and other organs, but similar approaches for the heart have been lacking. Here we generate complex, highly structured, three-dimensional heart-forming organoids (HFOs) by embedding human pluripotent stem cell aggregates in Matrigel followed by directed cardiac differentiation via biphasic WNT pathway modulation with small molecules. HFOs are composed of a myocardial layer lined by endocardial-like cells and surrounded by septum-transversum-like anlagen; they further contain spatially and molecularly distinct anterior versus posterior foregut endoderm tissues and a vascular network. The architecture of HFOs closely resembles aspects of early native heart anlagen before heart tube formation, which is known to require an interplay with foregut endoderm development. We apply HFOs to study genetic defects in vitro by demonstrating that NKX2.5 -knockout HFOs show a phenotype reminiscent of cardiac malformations previously observed in transgenic mice.

31 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
AFAriana Foinquinos
Ariana Foinquinos
SBSandor Batkai
Sandor Batkai
CGCelina Genschel
Celina Genschel
JVJanika Viereck
Janika Viereck
SRSteffen Rump
Steffen Rump
Thomas ThumThomas Thum
Thomas Thum
Despite proven efficacy of pharmacotherapies targeting primarily global neurohormonal dysregulation, heart failure (HF) is a growing pandemic with increasing burden. Treatments mechanistically focusing at the cardiomyocyte level are lacking. MicroRNAs (miRNA) are transcriptional regulators and essential drivers of disease progression. We previously demonstrated that miR-132 is both necessary and sufficient to drive the pathological cardiomyocytes growth, a hallmark of adverse cardiac remodelling. Therefore, miR-132 may serve as a target for HF therapy. Here we report further mechanistic insight of the mode of action and translational evidence for an optimized, synthetic locked nucleic acid antisense oligonucleotide inhibitor (antimiR-132). We reveal the compound’s therapeutic efficacy in various models, including a clinically highly relevant pig model of HF. We demonstrate favourable pharmacokinetics, safety, tolerability, dose-dependent PK/PD relationships and high clinical potential for the antimiR-132 treatment scheme.

1 July 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JRJeanne de la Roche
Jeanne de la Roche
MEMirjam J. Eberhardt
Mirjam J. Eberhardt
AKAlexandra B. Klinger
Alexandra B. Klinger
NSNancy Stanslowsky
Nancy Stanslowsky
FWFlorian Wegner
Florian Wegner
ALAndreas Leffler
Andreas Leffler
The surveillance of acid-base homeostasis is concerted by diverse mechanisms, including an activation of sensory afferents. Proton-evoked activation of rodent sensory neurons is mainly mediated by the capsaicin receptor TRPV1 and acid-sensing ion channels. In this study, we demonstrate that extracellular acidosis activates and sensitizes the human irritant receptor TRPA1 (hTRPA1). Proton-evoked membrane currents and calcium influx through hTRPA1 occurred at physiological acidic pH values, were concentration-dependent, and were blocked by the selective TRPA1 antagonist HC030031. Both rodent and rhesus monkey TRPA1 failed to respond to extracellular acidosis, and protons even inhibited rodent TRPA1. Accordingly, mouse dorsal root ganglion neurons lacking TRPV1 only responded to protons when hTRPA1 was expressed heterologously. This species-specific activation of hTRPA1 by protons was reversed in both mouse and rhesus monkey TRPA1 by exchange of distinct residues within transmembrane domains 5 and 6. Furthermore, protons seem to interact with an extracellular interaction site to gate TRPA1 and not via a modification of intracellular N-terminal cysteines known as important interaction sites for electrophilic TRPA1 agonists. Our data suggest that hTRPA1 acts as a sensor for extracellular acidosis in human sensory neurons and should thus be taken into account as a yet unrecognized transduction molecule for proton-evoked pain and inflammation. The species specificity of this property is unique among known endogenous TRPA1 agonists, possibly indicating that evolutionary pressure enforced TRPA1 to inherit the role as an acid sensor in human sensory neurons.

12 November 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TFTabea C. Fricke
Tabea C. Fricke
FEFrank Echtermeyer
Frank Echtermeyer
JZJohannes Zielke
Johannes Zielke
JRJeanne de la Roche
Jeanne de la Roche
MFMilos R. Filipovic
Milos R. Filipovic
MEMirjam Jeanette Eberhardt
Mirjam Jeanette Eberhardt
Thermosensitive transient receptor potential (TRP) ion channels detect changes in ambient temperature to regulate body temperature and temperature-dependent cellular activity. Rodent orthologs of TRP vanilloid 2 (TRPV2) are activated by nonphysiological heat exceeding 50 °C, and human TRPV2 is heat-insensitive. TRPV2 is required for phagocytic activity of macrophages which are rarely exposed to excessive heat, but what activates TRPV2 in vivo remains elusive. Here we describe the molecular mechanism of an oxidation-induced temperature-dependent gating of TRPV2. While high concentrations of H2O2 induce a modest sensitization of heat-induced inward currents, the oxidant chloramine-T (ChT), ultraviolet A light, and photosensitizing agents producing reactive oxygen species (ROS) activate and sensitize TRPV2. This oxidation-induced activation also occurs in excised inside-out membrane patches, indicating a direct effect on TRPV2. The reducing agent dithiothreitol (DTT) in combination with methionine sulfoxide reductase partially reverses ChT-induced sensitization, and the substitution of the methionine (M) residues M528 and M607 to isoleucine almost abolishes oxidation-induced gating of rat TRPV2. Mass spectrometry on purified rat TRPV2 protein confirms oxidation of these residues. Finally, macrophages generate TRPV2-like heat-induced inward currents upon oxidation and exhibit reduced phagocytosis when exposed to the TRP channel inhibitor ruthenium red (RR) or to DTT. In summary, our data reveal a methionine-dependent redox sensitivity of TRPV2 which may be an important endogenous mechanism for regulation of TRPV2 activity and account for its pivotal role for phagocytosis in macrophages. Significance Redox sensitivity is a common property of temperature-sensitive transient receptor potential (TRP) ion channels. Here we show that oxidation sensitizes and activates rodent TRPV2 orthologs known to have a high temperature threshold (>50 °C), but also the heat-insensitive human TRPV2. This oxidation-induced channel gating is intact in cell-free membrane patches, cysteine-independent but reduced upon replacement of the methionine residues M528 and M607. Blocking of TRPV2 and the reducing agent DTT reduce phagocytosis in macrophages which also generate heat-induced membrane currents following oxidation. These data reveal a methionine-dependent redox sensitivity of TRPV2 which may resemble a decisive endogenous mechanism enabling channel activation.

8 October 2024 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
MDMiriana Dardano
Miriana Dardano
FKFelix Kleemiß
Felix Kleemiß
MKMaike Kosanke
Maike Kosanke
DLDorina Lang
Dorina Lang
LWLiam Wilson
Liam Wilson
Robert ZweigerdtRobert Zweigerdt
Robert Zweigerdt
Despite the biomedical importance of haematopoietic stem cells and haematopoietic progenitor cells, their in vitro stabilization in a developmental context has not been achieved due to limited knowledge of signals and markers specifying the multiple haematopoietic waves as well as ethically restricted access to the human embryo. Thus, an in vitro approach resembling aspects of haematopoietic development in the context of neighbouring tissues is of interest. Our established human pluripotent stem cell-derived heart-forming organoids (HFOs) recapitulate aspects of heart, vasculature and foregut co-development. Modulating HFO differentiation, we here report the generation of blood-generating HFOs. While maintaining a functional ventricular-like heart anlagen, blood-generating HFOs comprise a mesenchyme-embedded haemogenic endothelial layer encompassing multiple haematopoietic derivatives and haematopoietic progenitor cells with erythro-myeloid and lymphoid potential, reflecting aspects of primitive and definitive haematopoiesis. The model enables the morphologically structured co-development of cardiac, endothelial and multipotent haematopoietic tissues equivalent to the intra-embryonic haematopoietic region in vivo, promoting research on haematopoiesis in vitro.

1 August 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JRJeanne de la Roche
Jeanne de la Roche
PAPaweorn Angsutararux
Paweorn Angsutararux
HKHenning Kempf
Henning Kempf
MJMontira Janan
Montira Janan
EBEmiliano Bolesani
Emiliano Bolesani
Robert ZweigerdtRobert Zweigerdt
Robert Zweigerdt
Loss-of-function mutations of the SCN5A gene encoding for the sodium channel α-subunit NaV1.5 result in the autosomal dominant hereditary disease Brugada Syndrome (BrS) with a high risk of sudden cardiac death in the adult. We here engineered human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) carrying the CRISPR/Cas9 introduced BrS-mutation p.A735V-NaV1.5 (g.2204C > T in exon 14 of SCN5A) as a novel model independent of patient´s genetic background. Recent studies raised concern regarding the use of hiPSC-CMs for studying adult-onset hereditary diseases due to cells’ immature phenotype. To tackle this concern, long-term cultivation of hiPSC-CMs on a stiff matrix (27–42 days) was applied to promote maturation. Patch clamp recordings of A735V mutated hiPSC-CMs revealed a substantially reduced upstroke velocity and sodium current density, a prominent rightward shift of the steady state activation curve and decelerated recovery from inactivation as compared to isogenic hiPSC-CMs controls. These observations were substantiated by a comparative study on mutant A735V-NaV1.5 channels heterologously expressed in HEK293T cells. In contrast to mutated hiPSC-CMs, a leftward shift of sodium channel inactivation was not observed in HEK293T, emphasizing the importance of investigating mechanisms of BrS in independent systems. Overall, our approach supports hiPSC-CMs’ relevance for investigating channelopathies in a dish.